Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.

World J Gastroenterol · 2022 · PMC9782844 · PMID 36569277

Europe PMC DOI

hedged sentences

0.0843

closest p · 1.7× alpha

0.0843

boldest claim

The sentences

trending towards significanceP = 0.0843so close (0.05 < p ≤ 0.1)

While the PSQ total score improved in the G-PUR ® group, it deteriorated in the placebo group, with the between-group difference in change over time trending towards significance ( P = 0.0843).

also in 515 other papers

showed a trendno p-value reported

Despite the pronounced placebo effect seen in this study, clinoptilolite showed a trend towards an augmented clinical benefit[ 19 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.